chr10-95643044-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 5 ACMG points: 5P and 0B. PM2PP3_ModeratePP5
The NM_002860.4(ALDH18A1):c.251G>A(p.Arg84Gln) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000013 in 1,613,856 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_002860.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 5 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ALDH18A1 | ENST00000371224.7 | c.251G>A | p.Arg84Gln | missense_variant | Exon 3 of 18 | 1 | NM_002860.4 | ENSP00000360268.2 | ||
ALDH18A1 | ENST00000371221.3 | c.251G>A | p.Arg84Gln | missense_variant | Exon 3 of 18 | 1 | ENSP00000360265.3 | |||
ALDH18A1 | ENST00000483788.1 | n.443G>A | non_coding_transcript_exon_variant | Exon 3 of 5 | 3 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152216Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000119 AC: 3AN: 251262Hom.: 0 AF XY: 0.00000736 AC XY: 1AN XY: 135808
GnomAD4 exome AF: 0.0000123 AC: 18AN: 1461640Hom.: 0 Cov.: 32 AF XY: 0.0000151 AC XY: 11AN XY: 727128
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152216Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74364
ClinVar
Submissions by phenotype
not provided Pathogenic:2Uncertain:1
- -
- -
Observed in trans with another ALDH18A1 variant in an individual with autosomal recessive spastic paraplegia in the literature (Steenhof et al., 2018); Not observed at a significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Published functional studies demonstrate severely reduced growth and enzymatic activity when expressed in CHO-K1 cells (Baumgartner et al., 2000), as well as reduced proline biosynthesis in patient fibroblasts (Baumgartner et al., 2005); Reported in ClinVar (ClinVar Variant ID# 16085; ClinVar); This variant is associated with the following publications: (PMID: 9622938, 29754261, 11092761, 27023906, 15517380) -
ALDH18A1-related de Barsy syndrome Pathogenic:2
- -
- -
de Barsy syndrome;C1832669:Autosomal dominant spastic paraplegia type 9;C4225268:Cutis laxa, autosomal dominant 3 Pathogenic:1
This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 84 of the ALDH18A1 protein (p.Arg84Gln). This variant is present in population databases (rs121434582, gnomAD 0.007%). This missense change has been observed in individuals with clinical features of autosomal recessive ALDH18A1-related conditions (PMID: 11092761, 27023906, 29754261). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 16085). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on ALDH18A1 protein function. Experimental studies have shown that this missense change affects ALDH18A1 function (PMID: 11092761). For these reasons, this variant has been classified as Pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at